Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Gorodetzky CW"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical pharmacology and therapeutics. 39(6)
The pharmacokinetics of single and combined doses of pentazocine HCl (40 and 80 mg) and tripelennamine HCl (50 and 100 mg) were studied in six healthy drug abusers. After intramuscular administration of 40 or 80 mg pentazocine alone, mean peak plasma
Autor:
Fava M; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Stahl SM; Department of Psychiatry and Neuroscience, University of California Riverside, Riverside, California.; Department of Psychiatry, University of California San Diego, San Diego, California., Pani L; Relmada Therapeutics, Inc, Coral Gables, Florida.; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Miami, Miami, Florida.; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy., De Martin S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy., Cutler AJ; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York.; Neuroscience Education Institute, Carlsbad, California., Maletic V; Department of Psychiatry/Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina., Gorodetzky CW; Consultant in Pharmaceutical Medicine, Kansas City, Missouri., Vocci FJ; Friends Research Institute, Baltimore, Maryland., Sapienza FL; The Drug and Chemical Advisory Group LLC, Fairfax, Virginia., Kosten TR; Baylor College of Medicine, MD Anderson Cancer Center, University of Houston, Houston, Texas., Kröger C; Relmada Therapeutics, Inc, Coral Gables, Florida., Champasa P; Relmada Therapeutics, Inc, Coral Gables, Florida., O'Gorman C; Relmada Therapeutics, Inc, Coral Gables, Florida., Guidetti C; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Child Neuropsychiatry Unit, Department of Neuroscience, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy., Alimonti A; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Comai S; Department of Pharmaceutical and Pharmacological Sciences, and Department of Biomedical Sciences, University of Padua, Padua, Italy.; Department of Psychiatry, McGill University, Montreal, Quebec, Canada., Mattarei A; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy., Folli F; Department of Health Sciences, University of Milan, Milan, Italy., Bushnell D; Cytel, Inc, Waltham, Massachusetts., Traversa S; Relmada Therapeutics, Inc, Coral Gables, Florida., Inturrisi CE; Relmada Therapeutics, Inc, Coral Gables, Florida., Manfredi PL; Relmada Therapeutics, Inc, Coral Gables, Florida.; Corresponding Author: Paolo L. Manfredi, MD, Relmada Therapeutics, 2222 Ponce de Leon Blvd Floor 3, Coral Gables, FL 33134 (pmanfredi@relmada.com)., Pappagallo M; Relmada Therapeutics, Inc, Coral Gables, Florida.
Publikováno v:
The Journal of clinical psychiatry [J Clin Psychiatry] 2024 Jun 17; Vol. 85 (3). Date of Electronic Publication: 2024 Jun 17.
Autor:
Pappagallo M; Relmada Therapeutics, Inc., Coral Gables, FL, USA., Kosten TR; Baylor College of Medicine, MD Anderson Cancer Center, University of Houston, Houston, TX, USA., Gorodetzky CW; Consultant in Pharmaceutical Medicine, Kansas City, MO, USA., Vocci FJ; Friends Research Institute, Baltimore, MD, USA., Sapienza FL; The Drug and Chemical Advisory Group LLC, Fairfax, VA, USA., De Martin S; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy., Comai S; Department of Pharmaceutical and Pharmacological Sciences, and Department of Biomedical Sciences, University of Padua, Padua, Italy.; Department of Psychiatry, McGill University, Montreal, QC, Canada., Mattarei A; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy., Inturrisi CE; Relmada Therapeutics, Inc., Coral Gables, FL, USA., Manfredi PL; Relmada Therapeutics, Inc., Coral Gables, FL, USA. pmanfredi@relmada.com.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2024 May 28. Date of Electronic Publication: 2024 May 28.
Autor:
Shram MJ; Altreos Research Partners, Toronto, Ontario, Canada., Henningfield JE; Pinney Associates, Bethesda, MD, USA., Apseloff G; Ohio Clinical Trials, Columbus, OH, USA., Gorodetzky CW; Relmada Therapeutics, Coral Gables, FL, USA.; Consultant in Pharmaceutical Medicine, Kansas City, MO, USA., De Martin S; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Vocci FL; Relmada Therapeutics, Coral Gables, FL, USA.; Friends Research Institute, Baltimore, MD, USA., Sapienza FL; Relmada Therapeutics, Coral Gables, FL, USA.; The Drug and Chemical Advisory Group LLC, Fairfax, VA, USA., Kosten TR; Relmada Therapeutics, Coral Gables, FL, USA.; Baylor College of Medicine, MD Anderson Cancer Center, University of Houston, Houston, TX, USA., Huston J; Ohio Clinical Trials, Columbus, OH, USA., Buchhalter A; Pinney Associates, Bethesda, MD, USA., Ashworth J; Pinney Associates, Bethesda, MD, USA., Lanier R; Pinney Associates, Bethesda, MD, USA., Folli F; Department of Health Science, University of Milan, Milan, Italy., Mattarei A; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Guidetti C; Child and Adolescent Neuropsychiatry Unit, Department of Neuroscience, Bambino Pediatric Hospital, IRCCS, Rome, Italy., Comai S; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., O'Gorman C; Relmada Therapeutics, Coral Gables, FL, USA., Traversa S; Relmada Therapeutics, Coral Gables, FL, USA., Inturrisi CE; Relmada Therapeutics, Coral Gables, FL, USA., Manfredi PL; Relmada Therapeutics, Coral Gables, FL, USA. pmanfredi@relmada.com., Pappagallo M; Relmada Therapeutics, Coral Gables, FL, USA.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2023 Jun 07; Vol. 13 (1), pp. 192. Date of Electronic Publication: 2023 Jun 07.
Autor:
Fishman M; Department of Psychiatry, Johns Hopkins School of Medicine and Maryland Treatment Centers, Baltimore, MD (MF); CARMA Health, PLLC, Austin, TX (CT); Northwestern Medicine Central DuPage Hospital, Winfield, IL (DA); Pharmaceutical Development and Regulatory Affairs, US WorldMeds, LLC, Louisville, KY (KG); Biometrics, US WorldMeds, LLC, Louisville, KY (TC); Consultant to US WorldMeds, LLC, Louisville, KY (CWG)., Tirado C, Alam D, Gullo K, Clinch T, Gorodetzky CW
Publikováno v:
Journal of addiction medicine [J Addict Med] 2019 May/Jun; Vol. 13 (3), pp. 169-176.
Autor:
Gorodetzky CW; Consultant in Pharmaceutical Medicine, 433 Ward Parkway, Unit 6S, Kansas City, MO, 64112, USA. Electronic address: cgoro@kc.rr.com., Walsh SL; Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky College of Medicine, 845 Angliana Avenue, Lexington, KY, 40508, USA., Martin PR; Department of Psychiatry and Behavioral Sciences, Vanderbilt University School of Medicine, 1601 23rd Avenue South, Suite 3068, Nashville, TN, 37232, USA., Saxon AJ; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine and VA Puget Sound Health Care System, 1660 S Columbian Way, S-116 Atc, Seattle, WA, 98108, USA., Gullo KL; US WorldMeds, LLC. 4441 Springdale Rd, Louisville, KY, 40241, USA., Biswas K; Cooperative Studies Program Coordinating Center (CSPCC), U.S. Department of Veterans Affairs, Perry Point, MD, 21902, USA.
Publikováno v:
Drug and alcohol dependence [Drug Alcohol Depend] 2017 Jul 01; Vol. 176, pp. 79-88. Date of Electronic Publication: 2017 May 10.